Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Alí Duarte‐García"'
Autor:
A. Jayatilleke, Jourdan Frankovich, Brittany A. Frankel, Yu Pei Chock, Irvin J Huang, Adam Kilian, Elizabeth R. Graef, Kristen J. Young, Sindhu R. Johnson, Kanika Monga, Sonia D. Silinsky Krupnikova, Carly Harrison, Michael S. Putman, Aneka Khilnani, Jean W. Liew, Jeffrey A. Sparks, Jorge A. Rosario Vega, Bharat Kumar, Ibrahim Almaghlouth, Alí Duarte-García, Laura A. Upton, Zachary S. Wallace, Namrata Singh, Rebecca Grainger, Ruth Fernandez-Ruiz, Laura C. Cappelli, Elaine Sullo
Publikováno v:
Seminars in Arthritis and Rheumatism
Highlights • This scoping review provides an up-to-date overview of published evidence regarding the frequency and severity of acute viral respiratory AEs related to antirheumatic disease therapies. • Glucocorticoid use was associated with a high
Autor:
Thomas L. Ortel, Hannah Cohen, Maria G Tektonidou, Doruk Erkan, Anisur Rahman, David J. Williams, Jason S. Knight, David A. Isenberg, Rohan Willis, Alí Duarte-García, Maria José Cuadrado, Jane E. Salmon, Scott C. Woller, Danieli Andrade
Publikováno v:
Lupus
Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid antibodies. The 16th International Congress on Antiphospholipid Antibodie
Publikováno v:
Current Opinion in Rheumatology. 32:215-227
Purpose of review Antiphospholipid syndrome (APS), more common than once believed, is an autoimmune disease best known for its high risk of incident and recurrent thrombotic events. The approach to treatment potentially differs from treatment of thro
Autor:
Maria Margarida Cunha, Gabriela Schmajuk, Rebecca Hasseli, Namrata Singh, Tiffany Y.T. Hsu, Milena A. Gianfrancesco, Anja Strangfeld, Ranjeny Thomas, Naomi J Patel, Thierry Thomas, Philippe Dieudé, Kimme L. Hyrich, Emily Sirotich, Laura Trupin, Liselotte Tidblad, Jinoos Yazdany, René Marc Flipo, Licia Maria Henrique da Mota, Andrea M Seet, Samar Al Emadi, Carolina A. Isnardi, Saskia Lawson-Tovey, Alí Duarte-García, Hendrik Schulze-Koops, Manuel F. Ugarte-Gil, Vanessa L. Kronzer, Philip Robinson, Lindsay Jacobsohn, Elsa F Mateus, Pedro Machado, Ana Paula Monteiro Gomides, Jean W. Liew, Guillermo A. Berbotto, Miguel Bernardes, Patricia P. Katz, Martin Schäfer, Guillermo J. Pons-Estel, Ulf Müller-Ladner, Jeffrey A. Sparks, Elena Nikiphorou, Christof Specker, Paul Sufka, Zara Izadi, Loreto Carmona, Stephanie Rush, Sandra Lúcia Euzébio Ribeiro, Maria O Valenzuela-Almada, Kristin M. D’Silva, Emily L Gilbert, Raphaèle Seror, Laure Gossec, Beth I Wallace, Viviane Angelina de Souza, Akpabio Akpabio, Jérôme Avouac, Leanna Wise, Wendy Costello, Zachary S. Wallace, Suleman Bhana, Jonathan S. Hausmann, Lianne Kearsley-Fleet, Bernd Raffeiner, Carlo Alberto Scirè, Rebecca Grainger
Publikováno v:
Annals of the Rheumatic Diseases
Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418
Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418
ObjectiveTo investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA).MethodsWe analysed the COVID-19 Global Rheumatology Alliance physician reg
Autor:
Alí Duarte-García, Manuel F. Ugarte-Gil, Jeffrey A. Sparks, Sebastian E. Sattui, Jean W. Liew, Carly Harrison, Francis Berenbaum, Michael S. Putman, Peter Korsten, Kristen J. Young, Emily Sirotich, Alfred H.J. Kim, Philip Robinson, Julia F. Simard, Rebecca Grainger, Laurie Proulx, Maximilian F. Konig, Elizabeth R. Graef, Dawn P. Richards
Publikováno v:
Annals of the Rheumatic Diseases
Ann Rheum Dis
Ann Rheum Dis
As of the end of March 2020, the covid-19 pandemic has resulted in over 850 000 confirmed cases and an estimated 42 000 deaths worldwide.1 All agree that safe and effective therapies for treatment and prevention are urgently needed. In the midst of t
Autor:
Eric L. Matteson, Kevin G. Moder, Cynthia S. Crowson, Shreyasee Amin, Kenneth J. Warrington, Alí Duarte-García, Rajiv K. Pruthi, Michael M. Pham
Publikováno v:
Arthritis & Rheumatology. 71:1545-1552
Objective To estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome (APS). Methods An inception cohort of patients with incident APS in 2000-2015 from a geographically well-defined populat
Autor:
Lihi Eder, Ana Maria Orbai, William Tillett, Robin Christensen, Oliver FitzGerald, Niti Goel, Lara Fallon, Chris A. Lindsay, Philip J. Mease, Alí Duarte-García, Dorcas E. Beaton, Ethan T. Craig, Maarten de Wit, Beverley Shea, Douglas J. Veale, Dafna D. Gladman, Vibeke Strand, Lara J Maxwell, Richard Holland, Ying Ying Leung, Laura C. Coates, Alexis Ogdie
Publikováno v:
J Rheumatol
Duarte-García, A, Leung, Y Y, Coates, L C, Beaton, D, Christensen, R, Craig, E T, de Wit, M, Eder, L, Fallon, L, FitzGerald, O, Gladman, D D, Goel, N, Holland, R, Lindsay, C, Maxwell, L, Mease, P, Orbai, A M, Shea, B, Strand, V, Veale, D J, Tillett, W & Ogdie, A 2019, ' Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity : OMERACT 2018 Psoriatic Arthritis workshop report ', Journal of Rheumatology, vol. 46, no. 8, pp. 996-1005 . https://doi.org/10.3899/jrheum.181089
Journal of Rheumatology, 46(8), 996-1005. Journal of Rheumatology
Duarte-García, A, Leung, Y Y, Coates, L C, Beaton, D, Christensen, R, Craig, E T, de Wit, M, Eder, L, Fallon, L, FitzGerald, O, Gladman, D D, Goel, N, Holland, R, Lindsay, C, Maxwell, L, Mease, P, Orbai, A M, Shea, B, Strand, V, Veale, D J, Tillett, W & Ogdie, A 2019, ' Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity : OMERACT 2018 Psoriatic Arthritis workshop report ', The Journal of Rheumatology, vol. 46, no. 8, pp. 996-1005 . https://doi.org/10.3899/jrheum.181089
Duarte-García, A, Leung, Y Y, Coates, L C, Beaton, D, Christensen, R, Craig, E T, De Wit, M, Eder, L, Fallon, L, FitzGerald, O, Gladman, D D, Goel, N, Holland, R, Lindsay, C, Maxwell, L, Mease, P, Orbai, A M, Shea, B, Strand, V, Veale, D J, Tillett, W & Ogdie, A 2019, ' Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity : OmeRACT 2018 Psoriatic Arthritis Workshop Report ', Journal of Rheumatology, vol. 46, no. 8, pp. 996-1005 . https://doi.org/10.3899/jrheum.181089
Duarte-García, A, Leung, Y Y, Coates, L C, Beaton, D, Christensen, R, Craig, E T, de Wit, M, Eder, L, Fallon, L, FitzGerald, O, Gladman, D D, Goel, N, Holland, R, Lindsay, C, Maxwell, L, Mease, P, Orbai, A M, Shea, B, Strand, V, Veale, D J, Tillett, W & Ogdie, A 2019, ' Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity : OMERACT 2018 Psoriatic Arthritis workshop report ', Journal of Rheumatology, vol. 46, no. 8, pp. 996-1005 . https://doi.org/10.3899/jrheum.181089
Journal of Rheumatology, 46(8), 996-1005. Journal of Rheumatology
Duarte-García, A, Leung, Y Y, Coates, L C, Beaton, D, Christensen, R, Craig, E T, de Wit, M, Eder, L, Fallon, L, FitzGerald, O, Gladman, D D, Goel, N, Holland, R, Lindsay, C, Maxwell, L, Mease, P, Orbai, A M, Shea, B, Strand, V, Veale, D J, Tillett, W & Ogdie, A 2019, ' Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity : OMERACT 2018 Psoriatic Arthritis workshop report ', The Journal of Rheumatology, vol. 46, no. 8, pp. 996-1005 . https://doi.org/10.3899/jrheum.181089
Duarte-García, A, Leung, Y Y, Coates, L C, Beaton, D, Christensen, R, Craig, E T, De Wit, M, Eder, L, Fallon, L, FitzGerald, O, Gladman, D D, Goel, N, Holland, R, Lindsay, C, Maxwell, L, Mease, P, Orbai, A M, Shea, B, Strand, V, Veale, D J, Tillett, W & Ogdie, A 2019, ' Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity : OmeRACT 2018 Psoriatic Arthritis Workshop Report ', Journal of Rheumatology, vol. 46, no. 8, pp. 996-1005 . https://doi.org/10.3899/jrheum.181089
Objective.The Psoriatic Arthritis (PsA) Core Domain Set for randomized controlled trials and longitudinal observational studies has recently been updated. The joint counts are central to the measurement of the peripheral arthritis component of the mu
Autor:
Kerry Wright, Paras Karmacharya, Delamo I. Bekele, Alí Duarte-García, Alexis Ogdie, Floranne C. Ernste, Cynthia S. Crowson, Megha M. Tollefson, John M. Davis, Sara J. Achenbach
Publikováno v:
J Rheumatol
ObjectiveTo examine demographic and clinical characteristics associated with diagnostic delay in psoriatic arthritis (PsA).MethodsWe characterized a retrospective, population-based cohort of incident adult (≥ 18 yrs) patients with PsA from Olmsted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5c2fb231af684e1fd2f31cd59616244
https://europepmc.org/articles/PMC8364557/
https://europepmc.org/articles/PMC8364557/
Antirheumatic disease therapies for the treatment of COVID‐19: A systematic review and meta‐analysis
Autor:
Alfred H.J. Kim, Adam Kilian, Sindhu R. Johnson, Maria I. Danila, Herman Tam, Jean W. Liew, Michael S. Putman, Peter Korsten, Catalina Sanchez-Alvarez, M. Hassan Murad, Francis Berenbaum, Yu Pei Eugenia Chock, Arundathi Jayatilleke, Andrea Peirce, Laura C Coates, Sebastian E. Sattui, Larry J. Prokop, Rebecca Grainger, Candace A Palmerlee, Zachary S. Wallace, Jeffrey A. Sparks, Alí Duarte-García
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis & Rheumatology
Arthritis & Rheumatology
Objective Antirheumatic disease therapies have been used to treat coronavirus disease 2019 (COVID‐19) and its complications. We conducted a systematic review and meta‐analysis to describe the current evidence. Methods A search of published and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066040af512dafa98b89f3ad05fa81ec
https://doi.org/10.1002/art.41469
https://doi.org/10.1002/art.41469
Autor:
Ariella Coler-Reilly, Peter Korsten, Alí Duarte-García, Emily Sirotich, Sebastian E. Sattui, Francis Berenbaum, Carly Harrison, Jeffrey A. Sparks, Manuel F. Ugarte-Gil, Maximilian F. Konig, Michael S. Putman, Jean W. Liew, Kate Webb, Kristen J. Young, Alfred H.J. Kim, Elizabeth R. Graef, Philip Robinson
Publikováno v:
Expert Review of Clinical Immunology
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Introduction Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications.